Visit the Resource Library

Recent trends in Parkinson’s research are focusing increasingly on early detection, precision medicine, and disease modification. Advances in biomarkers—such as changes in alpha-synuclein levels in cerebrospinal fluid and blood—are helping researchers identify Parkinson’s before motor symptoms emerge. Genetic studies are uncovering risk factors and potential therapeutic targets, especially around genes like LRRK2 and GBA. Meanwhile, innovative therapies such as focused ultrasound, stem cell treatments, and adaptive deep brain stimulation are showing promise. There's also a growing emphasis on the gut-brain connection, suggesting that gut health may play a crucial role in Parkinson’s onset and progression.